54
Views
0
CrossRef citations to date
0
Altmetric
Original Experimental and Clinical Research

Natural Antibiotic Susceptibility of Ewingella americana Strains

Pages 428-441 | Published online: 18 Jul 2013

REFERENCES

  • Grimont PA, Farmer JJ III, Grimont F, Asbury MA, Brenner DJ, Deval C. Ewingella americana gen. nov., sp. nov., a new Enterobacteriaceae isolated from clinical speci-mens. Ann Microbiol (Paris) 1983; 134A: 39–52.
  • Devreese K, Claeys G, Verschraegen G. Septicemia with Ewingella americana. J Clin Microbiol 1992; 30: 2746–7.
  • Maertens J, Delforge M, Vandenberghe P, Boogaerts M, Verhaegen J. Catheter-related bacteremia due to Ewingella americana. Clin Microb Infect 2001; 7: 103–4.
  • McNeil MM; Davis BJ, Solomon SL, Anderson RL, Shulman ST, Gardner S, Kabat, K, Martone WJ. Ewingella americana: recurrent pseudobacteremia from a persistent environmental reservoir. J Clin Microbiol 1987; 25: 498–500.
  • Pien FD, Bruce AE. Nosocomial Ewingella americana bacteremia in an intensive care unit. Arch Intern Med 1986; 146: 111–2.
  • Piene FD, Farmer JJ III, Weaver RE. Polymicrobial bac-teremia caused by Ewingella americana (family Enterobacteriaceae) and an unusual Pseudomonas species. J Clin Microbiol 1983; 18: 727–9.
  • Pumpuni CB, Beier MS, Nataro JP, Guers LD, Davis JR. Plasmodium falciparum: inhibition of sporogonic devel-opment in Anopheles stephensi by Gram-negative bacteria. Exp Parasitol 1993; 77: 195–99.
  • Muller HE, Fanning GR, Brenner DJ. Isolation of Ewingella americana from molluscs. Curr Microbiol 1995; 31: 287–90.
  • Inglis PW, Peberdy JF. Isolation of Ewingella ameri-cana from the cultivated mushroom, Agaricus bisporus. Curr Microbiol 1996; 33: 334–7.
  • Bear N, Klugman KP, Tobiansky L, Koornhof HJ. Wound colonization by Ewingella americana. J Clin Microbiol 1986; 23: 650–1.
  • Da Costa PS, Tostes MM; de Carvalho Valle MM. A case of keratoconjunctivitis due to Ewingella americana and a review of unusual organisms causing external eye infections. Braz J Infect Dis 2000; 4: 262–7.
  • Farmer JJ III, Davis BR, Hickman-Brenner FW, McWhorter A, Huntley-Carter GP, Asbury MA, et al. Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens. J Clin Microbiol 1985; 21: 46–76.
  • Heizmann WR, Michel R. Isolation of Ewingella ameri-cana from a patient with conjunctivitis. Eur J Clin Microbiol Infect Dis 1991; 10: 957–9.
  • Kati C, Bibashi E, Kokolina E, Sofianou D. Case of peritonitis caused by Ewingella americana in a patient under-going continuous ambulatory peritoneal dialysis. J Clin Microbiol 1999; 37: 3733–4.
  • Tsokos M. Fatal Waterhouse-Friderichsen Syndrome due to Ewingella americana infection. Am J Foren Med Pathol 2003; 24: 41–4.
  • McNeil MM, Davis BJ, Anderson RL, Clark N, Cooksey RC, O'Hara CM, et al. Plasmids of Ewingella americana: supplementary epidemiologic markers in an outbreak of pseudobacteremia. J Clin Microbiol 1987; 25: 501–3.
  • Nash P, Krenz MM. Culture media. In Balows A, Hausler Jr EJ, Herrmann KL, Isenberg HD, Shadomy HD, editors. Manual of Clinical Microbiology. New York: American Society of Microbiology, 1991: 1226-1228.
  • Stock I, Wiedemann B. Natural β-lactam susceptibility and mechanisms of β-lactam resistance in Yersinia enteroco-litica. Rev Med Microbiol 2000; 11: 197–210.
  • Deutsches Institut für Normung e.V. Susceptibility test-ing of pathogens to antimicrobial agents, part 4: Evaluation classes of the minimum inhibitory concentration. MIC break-points of antibacterial agents. DIN document 58940-4, Supplement 1. Deutsches Institut fur Normung e.V., 2000, Berlin, Germany.
  • Comite de l'Antibiogramme de la Societe Française de Microbiologie Communique. Statement. Pathol Biol 1998; 46: I–XVI.
  • Olsson-Liljequist B, Larson P, Walder M, Miörner H. Antimicrobial susceptibility testing in Sweden. Part 3: Methology for susceptibility testing. Scand J Infect Dis 1997; 105 (Suppl.): 13-23.
  • National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing; Twelfth Informational Supplement. NCCLS document M100-512. National Committee for Clinical Laboratory Standards, 2002, Wayne, Pa, USA.
  • Soussy CJ, Goldstein F, Bryskier A, Drugeon H, Andrews J, Baquero F, et al. Telithromycin: assessment of susceptibility testing. International Congress of Antimicrobial Agents and Chemotherapy, Toronto, 2000.
  • Stone G, Nilius A, Hensey D, Almer L, Beyer J, Flamm R. Development of tentative interpretive criteria for ABT-773, a novel ketolide antibacterial agent. International Congress of Antimicrobial Agents and Chemotherapy, Toronto, 2000.
  • European Committee on Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Linezolid breakpoints. Clin Microbiol Infect 2001; 7: 283–284.
  • Troxler R, von Graevenitz A, Funke G, Wiedemann B, Stock I. Natural antibiotic susceptibility of Listeria species: L. grayi, L. innocua, L. Wanouii, L. monocytogenes, L. seel-igeri and L. welsh imeri strains. Clin Microbiol Infect 2000; 6: 525–35.
  • Stock I, Burak S, Sherwood KJ, Grüger T, Wiedemann B. Natural antimicrobial susceptibilities of strains of ‘unusual’ Serratia species: S. ficaria, S. fonticola, S. odorifera, S. ply-muthica and S. rubidaea. J Antimicrob Chemother 2003; 51: 865–85.
  • Farmer JJ III. Enterobacteriaceae: introduction and identification. In Murray P, Baron E, Pfaller M, Tenover F, Yolken R, editors. Manual of Clinical Microbiology. New York: American Society of Microbiology, 1995: 438-449.
  • Gavini F, Mergaert J, Beji A, Mielcarek C, Izard D, Kersters K, De Ley J. Transfer of Enterobacter agglomerans (Beijerinck 1888) Ewing and Fife 1972 to Pan toea gen. nov. as Pantoea agglomerans comb. nov. and description of Pan toea dispersa sp. nov. Int J Syst Bacteriol 1989; 39: 337–45.
  • Livermore DM. β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557–84.
  • Stock I. Die natürliche Antibiotika-Empfindlichkeit der Enterobacteriaceae. Dissertation, Bonn, 1999.
  • Nikaido H. Outer membrane. In Neidhardt FC, editor. Escherichia coli and Salmonella Typhimurium, cellular and molecular biology. Washington, DC: American Society of Microbiology, 1996: 29-47.
  • Farmer S, Li ZS, Hancock REW. Influence of outer membrane mutations on susceptibility of Escherichia coli to the dibasic macrolide azithromycin. J Antimicrob Chemother 1992; 29: 27–33.
  • Hancock REW. Bacterial outer membranes: evolving concepts. Specific structures provide gram-negative bacteria with several unique advantages. ASM News 1991; 57: 175–82.
  • O'Hara K. Two different types of fosfomycin resistance in clinical isolates of Klebsiella pneumoniae. FEMS Microbiol Lett 1993; 114: 9–16.
  • Patel SS, Balfour JA, Bryson HM. Fosfomycin tromethamine. A review of its antibacterial activity, pharmaco-kinetic properties and therapeutic eficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infec-tions. Drugs 1997; 53: 637–56.
  • Kresken M, Hafner D and the study group ‘Resistance’ of the Paul Ehrlich Society for Chemotherapie e.V. Resistenzsituation bei klinisch wichtigen Infektionserregern gegentiber Chemotherapeutika in Mitteleuropa. Chemother J 2000; 9: 51-86 (In German).
  • Stock I, Falsen E, Wiedemann B. Moellerella wiscon-sensis: identification, natural antibiotic susceptibility and its dependency on the medium applied. Diagn Microbiol Infect Dis 2003; 45: 1–11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.